These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23696668)

  • 1. The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization.
    Wu MC; Brennan FH; Lynch JP; Mantovani S; Phipps S; Wetsel RA; Ruitenberg MJ; Taylor SM; Woodruff TM
    Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9439-44. PubMed ID: 23696668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow.
    Ratajczak J; Reca R; Kucia M; Majka M; Allendorf DJ; Baran JT; Janowska-Wieczorek A; Wetsel RA; Ross GD; Ratajczak MZ
    Blood; 2004 Mar; 103(6):2071-8. PubMed ID: 14604969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli-induced kidney injury in mice.
    Wu KY; Zhang T; Zhao GX; Ma N; Zhao SJ; Wang N; Wang JX; Li ZF; Zhou W; Li K
    Kidney Int; 2019 Sep; 96(3):612-627. PubMed ID: 31133456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
    Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
    Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell Responses.
    Nabizadeh JA; Manthey HD; Steyn FJ; Chen W; Widiapradja A; Md Akhir FN; Boyle GM; Taylor SM; Woodruff TM; Rolfe BE
    J Immunol; 2016 Jun; 196(11):4783-92. PubMed ID: 27183625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration.
    Wu MCL; Lee JD; Ruitenberg MJ; Woodruff TM
    J Immunol; 2020 Nov; 205(10):2834-2839. PubMed ID: 33028618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3a and C5a promote renal ischemia-reperfusion injury.
    Peng Q; Li K; Smyth LA; Xing G; Wang N; Meader L; Lu B; Sacks SH; Zhou W
    J Am Soc Nephrol; 2012 Sep; 23(9):1474-85. PubMed ID: 22797180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
    Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
    J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2.
    Brennan FH; Jogia T; Gillespie ER; Blomster LV; Li XX; Nowlan B; Williams GM; Jacobson E; Osborne GW; Meunier FA; Taylor SM; Campbell KE; MacDonald KP; Levesque JP; Woodruff TM; Ruitenberg MJ
    JCI Insight; 2019 May; 4(9):. PubMed ID: 31045582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockout of the C3a receptor protects against renal ischemia reperfusion injury by reduction of NETs formation.
    Wu X; You D; Pan M; Weng M; Xie Q; Guan Y; Zheng J; Lin S; Zhang X; Hao C; Wan J
    Cell Mol Life Sci; 2023 Oct; 80(11):322. PubMed ID: 37816851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement factor C5a mediates renal ischemia-reperfusion injury independent from neutrophils.
    de Vries B; Köhl J; Leclercq WK; Wolfs TG; van Bijnen AA; Heeringa P; Buurman WA
    J Immunol; 2003 Apr; 170(7):3883-9. PubMed ID: 12646657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.
    Proctor LM; Arumugam TV; Shiels I; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2004 Jun; 142(4):756-64. PubMed ID: 15159277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
    Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
    J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice.
    Banda NK; Hyatt S; Antonioli AH; White JT; Glogowska M; Takahashi K; Merkel TJ; Stahl GL; Mueller-Ortiz S; Wetsel R; Arend WP; Holers VM
    J Immunol; 2012 Feb; 188(3):1469-78. PubMed ID: 22205026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice.
    Lim H; Kim YU; Drouin SM; Mueller-Ortiz S; Yun K; Morschl E; Wetsel RA; Chung Y
    PLoS One; 2012; 7(12):e52666. PubMed ID: 23285141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.
    Zwirner J; Götze O; Begemann G; Kapp A; Kirchhoff K; Werfel T
    Immunology; 1999 May; 97(1):166-72. PubMed ID: 10447728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein inhibits C3a/C3aR-dependent podocyte autophagy in favor of diabetic kidney disease.
    Zhang L; Li W; Gong M; Zhang Z; Xue X; Mao J; Zhang H; Li S; Liu X; Wu F; Shi J; Fu G
    FASEB J; 2022 Jun; 36(6):e22332. PubMed ID: 35503088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis.
    Ramos TN; Wohler JE; Barnum SR
    Neurosci Lett; 2009 Dec; 467(3):234-6. PubMed ID: 19850104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.